We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App





Mindray Demonstrates Latest IVD Innovations at EUROMEDLAB 2022

By Carolyn Moody, RN - News Editor
Posted on 11 Apr 2022
Print article
Image: Mindray’s total laboratory solutions ensure greater efficiency (Photo courtesy of Mindray)
Image: Mindray’s total laboratory solutions ensure greater efficiency (Photo courtesy of Mindray)

Mindray (Shenzhen, China) displayed its latest laboratory innovations at the 24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, EUROMEDLAB 2022, in Munich, Germany. EUROMEDLAB is the most influential platform in Europe where new ideas and technologies in laboratory diagnostics are shared and showcased. Mindray’s wide range of IVD products attracted customers from Europe and other parts of the world.

At EUROMEDLAB 2022, Mindray displayed the new MC-80 automated digital cell morphology analyzer that is taking digital morphology analysis to the next level by delivering clearer images which are able to capture abnormalities in more detail. With advanced algorithms, the analyzer enables better identification of different cells with high throughput, resulting in greater productivity. Its high-performance objective and advanced image sensor offer ultra resolution images to reappear the real view under the microscope. The MC-80 has an industry-leading throughput of 60 slides per hour and features a solid rock hyper-stable anti-shake system. Aerospace materials and cutting-edge high-frequency exposure algorithm are integrated to eliminate blurred images.

Mindray also demonstrated the new CAL 8000 New Generation Cellular Analysis Line which marks the company’s expertise and innovative power in hematology area for large-scale laboratories. It has higher throughput per square meter, upgraded labXpert Data Management Software, flexible layout design options, and other advanced functionalities. Combining Mindray’s new MC-80 digital cell morphology analyzer, the CAL 8000 is taking hematology analysis automation to the next level. The touch screen is the “brain” of CAL 8000. It optimizes the distribution of workload between each analyzer unit and decides which sample requires a blood smear. It displays the status of each analyzer or SC-120 installed on CAL 8000 as well as the volume of balance reagent. This intuitive software can tell the users all necessary information of CAL 8000 at any given time. Consequently, users spend less time operating CAL 8000 and can arrange their working schedule better. Additionally, Mindray exhibited its M6000 laboratory automation system which can empower ultra high volume laboratories with high processing speed, less hands-on time, great cost efficiency and standardized analytical quality.

Related Links:
Mindray 

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Centrifuge
Hematocrit Centrifuge 7511M4
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.